NEUROPACE, INC. Investment Income, Interest
NEUROPACE, INC. (NPCE) reported Investment Income, Interest of $523.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-11
- NEUROPACE, INC. investment income, interest for the quarter ending 2026-06-30 was $523.00K, a 27.16% decline year-over-year.
- NEUROPACE, INC. investment income, interest for the quarter ending 2026-03-31 was $565.00K, a 28.75% decline year-over-year.
- NEUROPACE, INC. investment income, interest for the quarter ending 2025-12-31 was $638.00K, a 6.31% decline year-over-year.
- NEUROPACE, INC. investment income, interest for the quarter ending 2025-09-30 was $667.00K, a 11.54% decline year-over-year.
- NEUROPACE, INC. investment income, interest for fiscal 2025 was $2.82M, a 6.88% decline from fiscal 2024.
- NEUROPACE, INC. investment income, interest for fiscal 2024 was $3.02M, a 0.85% decline from fiscal 2023.
- NEUROPACE, INC. investment income, interest for fiscal 2023 was $3.05M, a 93.28% increase from fiscal 2022.
- NEUROPACE, INC. investment income, interest for fiscal 2022 was $1.58M, a 252.23% increase from fiscal 2021.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $523.00K 10-Q · filed 2026-08-11 | $1.09M 10-Q · filed 2026-08-11 | $1.73M derived: sum of 3 quarters · filed 2026-08-11 | $2.39M derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $565.00K 10-Q · filed 2026-05-12 | $1.20M derived: sum of 2 quarters · filed 2026-05-12 | $1.87M derived: sum of 3 quarters · filed 2026-05-12 | $2.59M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $638.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $1.30M derived: sum of 2 quarters · filed 2026-03-03 | $2.02M derived: sum of 3 quarters · filed 2026-08-11 | $2.82M 10-K · filed 2026-03-03 |
| 2025-09-30 | $667.00K 10-Q · filed 2025-11-04 | $1.39M derived: sum of 2 quarters · filed 2026-08-11 | $2.18M 10-Q · filed 2025-11-04 | $2.86M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $718.00K 10-Q · filed 2026-08-11 | $1.51M 10-Q · filed 2026-08-11 | $2.19M derived: sum of 3 quarters · filed 2026-08-11 | $2.95M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $793.00K 10-Q · filed 2026-05-12 | $1.47M derived: sum of 2 quarters · filed 2026-05-12 | $2.23M derived: sum of 3 quarters · filed 2026-05-12 | $2.99M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $681.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $1.44M derived: sum of 2 quarters · filed 2026-03-03 | $2.20M derived: sum of 3 quarters · filed 2026-03-03 | $3.02M 10-K · filed 2026-03-03 |
| 2024-09-30 | $754.00K 10-Q · filed 2025-11-04 | $1.52M derived: sum of 2 quarters · filed 2025-11-04 | $2.34M 10-Q · filed 2025-11-04 | $3.17M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $762.00K 10-Q · filed 2025-08-12 | $1.59M 10-Q · filed 2025-08-12 | $2.41M derived: sum of 3 quarters · filed 2025-08-12 | $3.18M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $827.00K 10-Q · filed 2025-05-13 | $1.65M derived: sum of 2 quarters · filed 2025-05-13 | $2.42M derived: sum of 3 quarters · filed 2025-05-13 | $3.15M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $822.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | $1.59M derived: sum of 2 quarters · filed 2025-03-04 | $2.32M derived: sum of 3 quarters · filed 2025-03-04 | $3.05M 10-K · filed 2025-03-04 |
| 2023-09-30 | $769.00K 10-Q · filed 2024-11-12 | $1.50M derived: sum of 2 quarters · filed 2024-11-12 | $2.23M 10-Q · filed 2024-11-12 | $3.03M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $733.00K 10-Q · filed 2024-08-13 | $1.46M 10-Q · filed 2024-08-13 | $2.26M derived: sum of 3 quarters · filed 2024-08-13 | $2.68M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $726.00K 10-Q · filed 2024-05-08 | $1.53M derived: sum of 2 quarters · filed 2024-05-08 | $1.95M derived: sum of 3 quarters · filed 2024-05-08 | $2.17M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $1.22M derived: sum of 2 quarters · filed 2024-03-05 | $1.44M derived: sum of 3 quarters · filed 2024-03-05 | $1.58M 10-K · filed 2024-03-05 |
| 2022-09-30 | $423.00K 10-Q · filed 2023-11-06 | $644.00K derived: sum of 2 quarters · filed 2023-11-06 | $778.00K 10-Q · filed 2023-11-06 | $964.00K derived: sum of 4 quarters · filed 2023-11-06 |
| 2022-06-30 | $221.00K 10-Q · filed 2023-08-08 | $355.00K 10-Q · filed 2023-08-08 | $541.00K derived: sum of 3 quarters · filed 2023-08-08 | $677.00K derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $134.00K 10-Q · filed 2023-05-04 | $320.00K derived: sum of 2 quarters · filed 2023-05-04 | $456.00K derived: sum of 3 quarters · filed 2023-05-04 | $556.00K derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | $186.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $322.00K derived: sum of 2 quarters · filed 2023-03-02 | $422.00K derived: sum of 3 quarters · filed 2023-03-02 | $448.00K 10-K · filed 2023-03-02 |
| 2021-09-30 | $136.00K 10-Q · filed 2022-11-08 | $236.00K derived: sum of 2 quarters · filed 2022-11-08 | $262.00K 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $100.00K 10-Q · filed 2022-08-11 | $126.00K 10-Q · filed 2022-08-11 | ||
| 2021-03-31 | $26.00K 10-Q · filed 2022-05-12 | |||
| 2020-12-31 | $41.00K 10-K · filed 2022-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |